Cargando…

Immunohistochemical Expression of E- and N-Cadherin in Nodular Prostatic Hyperplasia and Prostatic Carcinoma

BACKGROUND: Different theories have been postulated to explain the development of nodular prostatic hyperplasia (NPH). Epithelial to mesenchymal transition (EMT) is a physiologic process in which the epithelial cells lose their polarity and cell-cell adhesion and acquire a mesenchymal phenotype. AIM...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdallah, Rania Abdallah, Abdou, Asmaa Gaber, Abdelwahed, Moshira, Ali, Hend
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442322/
https://www.ncbi.nlm.nih.gov/pubmed/31008053
http://dx.doi.org/10.4103/JMAU.JMAU_46_18
_version_ 1783407693278478336
author Abdallah, Rania Abdallah
Abdou, Asmaa Gaber
Abdelwahed, Moshira
Ali, Hend
author_facet Abdallah, Rania Abdallah
Abdou, Asmaa Gaber
Abdelwahed, Moshira
Ali, Hend
author_sort Abdallah, Rania Abdallah
collection PubMed
description BACKGROUND: Different theories have been postulated to explain the development of nodular prostatic hyperplasia (NPH). Epithelial to mesenchymal transition (EMT) is a physiologic process in which the epithelial cells lose their polarity and cell-cell adhesion and acquire a mesenchymal phenotype. AIM: The aim of the present study is to investigate the potential role of E- and N-cadherin in the induction of EMT in NPH and prostatic carcinoma. METHODS: This study was carried out on 55 cases of NPH and 20 cases prostatic carcinoma for evaluation of immunohistochemical expression of E and N cadherins. RESULTS: Most NPH (54/55 cases, 98.2%) and all cases of prostatic carcinoma showed positive N-cadherin expression in prostatic glands and stroma. High percentage of N-cadherin expression by stromal cells was significantly in favor of prostatic carcinoma compared to NPH. High percentage of N-cadherin expression by epithelial cells of carcinoma group was significantly associated with young age while its high expression by stromal cells was significantly associated with multicentricity. About 96.4% of NPH and 75% of prostatic carcinoma showed positive E-cadherin expression with a significant difference. No significant association between E-cadherin and N-cadherins in both NPH and prostatic carcinoma was identified. CONCLUSIONS: The prominent expression of N-cadherin in large numbers of NPH and prostate carcinoma cases in the epithelial and stromal components could point to the occurrence of EMT in those diseases. It also opens a new gate for treatment of those patients by targeting N-cadherin molecule. The absence of inverse association between E-cadherin and N-cadherins in NPH and prostatic carcinoma may indicate that cadherin switch is not an essential step for the development of EMT.
format Online
Article
Text
id pubmed-6442322
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-64423222019-04-19 Immunohistochemical Expression of E- and N-Cadherin in Nodular Prostatic Hyperplasia and Prostatic Carcinoma Abdallah, Rania Abdallah Abdou, Asmaa Gaber Abdelwahed, Moshira Ali, Hend J Microsc Ultrastruct Original Article BACKGROUND: Different theories have been postulated to explain the development of nodular prostatic hyperplasia (NPH). Epithelial to mesenchymal transition (EMT) is a physiologic process in which the epithelial cells lose their polarity and cell-cell adhesion and acquire a mesenchymal phenotype. AIM: The aim of the present study is to investigate the potential role of E- and N-cadherin in the induction of EMT in NPH and prostatic carcinoma. METHODS: This study was carried out on 55 cases of NPH and 20 cases prostatic carcinoma for evaluation of immunohistochemical expression of E and N cadherins. RESULTS: Most NPH (54/55 cases, 98.2%) and all cases of prostatic carcinoma showed positive N-cadherin expression in prostatic glands and stroma. High percentage of N-cadherin expression by stromal cells was significantly in favor of prostatic carcinoma compared to NPH. High percentage of N-cadherin expression by epithelial cells of carcinoma group was significantly associated with young age while its high expression by stromal cells was significantly associated with multicentricity. About 96.4% of NPH and 75% of prostatic carcinoma showed positive E-cadherin expression with a significant difference. No significant association between E-cadherin and N-cadherins in both NPH and prostatic carcinoma was identified. CONCLUSIONS: The prominent expression of N-cadherin in large numbers of NPH and prostate carcinoma cases in the epithelial and stromal components could point to the occurrence of EMT in those diseases. It also opens a new gate for treatment of those patients by targeting N-cadherin molecule. The absence of inverse association between E-cadherin and N-cadherins in NPH and prostatic carcinoma may indicate that cadherin switch is not an essential step for the development of EMT. Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6442322/ /pubmed/31008053 http://dx.doi.org/10.4103/JMAU.JMAU_46_18 Text en Copyright: © 2019 Journal of Microscopy and Ultrastructure http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Abdallah, Rania Abdallah
Abdou, Asmaa Gaber
Abdelwahed, Moshira
Ali, Hend
Immunohistochemical Expression of E- and N-Cadherin in Nodular Prostatic Hyperplasia and Prostatic Carcinoma
title Immunohistochemical Expression of E- and N-Cadherin in Nodular Prostatic Hyperplasia and Prostatic Carcinoma
title_full Immunohistochemical Expression of E- and N-Cadherin in Nodular Prostatic Hyperplasia and Prostatic Carcinoma
title_fullStr Immunohistochemical Expression of E- and N-Cadherin in Nodular Prostatic Hyperplasia and Prostatic Carcinoma
title_full_unstemmed Immunohistochemical Expression of E- and N-Cadherin in Nodular Prostatic Hyperplasia and Prostatic Carcinoma
title_short Immunohistochemical Expression of E- and N-Cadherin in Nodular Prostatic Hyperplasia and Prostatic Carcinoma
title_sort immunohistochemical expression of e- and n-cadherin in nodular prostatic hyperplasia and prostatic carcinoma
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442322/
https://www.ncbi.nlm.nih.gov/pubmed/31008053
http://dx.doi.org/10.4103/JMAU.JMAU_46_18
work_keys_str_mv AT abdallahraniaabdallah immunohistochemicalexpressionofeandncadherininnodularprostatichyperplasiaandprostaticcarcinoma
AT abdouasmaagaber immunohistochemicalexpressionofeandncadherininnodularprostatichyperplasiaandprostaticcarcinoma
AT abdelwahedmoshira immunohistochemicalexpressionofeandncadherininnodularprostatichyperplasiaandprostaticcarcinoma
AT alihend immunohistochemicalexpressionofeandncadherininnodularprostatichyperplasiaandprostaticcarcinoma